MedAvail Holdings Inc. (MDVL): Price and Financial Metrics

MedAvail Holdings Inc. (MDVL): $1.80

1.23 (-40.59%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

F

Add MDVL to Watchlist
Sign Up

Industry: Medical - Drug Stores

Industry

NR

Ranked

#5 of 5

in industry

MDVL Price/Volume Stats

Current price $1.80 52-week high $20.89
Prev. close $3.03 52-week low $1.31
Day low $1.74 Volume 245,100
Day high $2.54 Avg. volume 261,432
50-day MA $3.27 Dividend yield N/A
200-day MA $8.27 Market Cap 2.91M

MDVL Stock Price Chart Interactive Chart >


MedAvail Holdings Inc. (MDVL) Company Bio


MedAvail is a technology-enabled pharmacy organization that embeds pharmacy services directly into clinics and other points of care. The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations.


MDVL Latest News Stream


Event/Time News Detail
Loading, please wait...

MDVL Latest Social Stream


Loading social stream, please wait...

View Full MDVL Social Stream

Latest MDVL News From Around the Web

Below are the latest news stories about MEDAVAIL HOLDINGS INC that investors may wish to consider to help them evaluate MDVL as an investment opportunity.

MedAvail Announces Agreement with New Orleans-Based St. Thomas Community Health Centers for Deployment of Two M4 MedCenters

Expands MedAvail’s presence among Federally Qualified Health Centers (FQHCs)PHOENIX, Nov. 28, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that it has entered into an agreement with New Orleans-based St. Thomas Community Health Centers for the deployment of two M4 MedCenter kiosks. St. Thomas operates eight Federally Qualified Health Centers (FQHCs), providing affordable health care to underserved communi

Yahoo | November 28, 2023

MedAvail Receives Nasdaq Notification of Non-Compliance Related to Delayed Quarterly Report on Form 10-Q

PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology company, announced today that on November 16, 2023, the Company received a delinquency notification letter from the Listing Qualifications Department of the Nasdaq Stock Market indicating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to have timely filed its Quarterly Report on Form 10-Q for the

Yahoo | November 17, 2023

MedAvail Announces Agreement with ASP Cares for Deployment of Ten M4 MedCenters

Initial three deployments to be completed in early 2024 at ASP Cares Pharmacy in Las Vegas Agreement repsents expansion of successful relationship with Dallas-based Oak Lawn Pharmacy PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that it has entered into an agreement with Pharmacy Fund 1 for the deployment of ten M4 MedCenter kiosks, which will be serviced by ASP Cares Pharmacy. Pharmacy F

Yahoo | November 17, 2023

MedAvail to Participate in H.C. Wainwright 25th Annual Global Investment Conference

PHOENIX, Aug. 30, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), an innovative pharmacy technology company, announced today that Mark Doerr, Chief Executive Officer, will participate in H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023. A recording of the event will be available at 7:00am ET on September 11, 2023 on the investor relations section of MedAvail’s website at https://investors.medavail.com and will be archived for 90

Yahoo | August 30, 2023

Potential Upside For MedAvail Holdings, Inc. (NASDAQ:MDVL) Not Without Risk

There wouldn't be many who think MedAvail Holdings, Inc.'s ( NASDAQ:MDVL ) price-to-sales (or "P/S") ratio of 0.5x is...

Yahoo | August 16, 2023

Read More 'MDVL' Stories Here

MDVL Price Returns

1-mo N/A
3-mo N/A
6-mo -49.44%
1-year -87.63%
3-year -99.74%
5-year N/A
YTD -59.91%
2023 -70.05%
2022 -78.59%
2021 -90.70%
2020 3.65%
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!